Outpatient clinic for genetic counseling and gene testing of retinoblastoma

International Journal of Clinical Oncology

Volumn 9, Issue 1, 2004, Pages 25-30

  Sugano, Kokichi ^a,b   Yoshida, Teruhiko ^a,c   Izumi, Hideko ^a   Umezawa, Shino ^a   Ushiama, Mineko ^c   Ichikawa, Akira ^b   Hidaka, Akio ^a,d   Murakami, Yoshinori ^c   Kodama, Tetsurou ^a   Suzuki, Shigenobu ^a   Kaneko, Akihiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b TOCHIGI CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Gene testing; Genetic counseling; Hereditary cancer; RB1 gene; Retinoblastoma

Indexed keywords

CANCER CENTER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; FAMILIAL DISEASE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; GENETIC RISK; HOSPITAL; HUMAN; JAPAN; METASTASIS; OUTPATIENT DEPARTMENT; PARENT; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROGNOSIS; RETINOBLASTOMA; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

AMBULATORY CARE FACILITIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INCIDENCE; JAPAN; PEDIGREE; PHENOTYPE; PRIMARY PREVENTION; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 11144356087     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0382-8     Document Type: Review

References (8)

1. The Committee for the National Registry of Retinoblastoma (1992) National Registry of Retinoblastoma in Japan (1975-1982). Acta Soc Ophthalmol Jpn 96:1433-1442
2. Online mendelian inheritance in man, OMIM (TM). McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2000. http://www.ncbi.nlm.nih.gov/omim
3. American Society of Clinical Oncology (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 14:1730-1736
4. Matsunaga E (1978) Recurrence risk to relatives of patients with retinoblastoma. Jpn J Ophthalmol 22:313-319
5. Hanson IM, Seawright A, Hardman K, et al. (1993) PAX6 mutations in aniridia. Hum Mol Genet 2:915-920
6. Wong FL, Boice JD Jr, Abramson DH, et al. (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278:1262-1267
7. Abramson DH, Mendelsohn ME, Servodidio CA, et al. (1998) Familial retinoblastoma: where and when? Acta Ophthalmol Scand 76:334-338
8. Moll AC, Imhof SM, Meeteren AY, et al. (2000) At what age could screening for familial retinoblastoma be stopped? A register-based study 1945-98. Br J Ophthalmol 84:1170-1172